Share
2,365 Posts.
lightbulb Created with Sketch. 640
clock Created with Sketch. 18/11/19
15:41
Share
Originally posted by gutumike:
↑
Hi Mechanic, you correctly identify horticulture, distribution and government regulation as important factors which can adversely affect companies involved in the cultivation of cannabis and hemp, and in the production and marketing of medicinal cannabis products, but an important factor which I believe is even more critical is the very significant oversupply of raw cannabis and hemp which is likely to flood the market in 2020 on a worldwide basis. I believe that this will depress prices to the point where many companies which have already been unable to operate on a cash-flow-positive basis will struggle to survive.
Expand
only time will be the judge, but there are certainly lower risk ASX entities to buy ,the other issue is supply quality in the USA in particular which has contributed to the variaitions in broader legislation across the USA lets hope the Canadian products and markets CGB are directly associated with fare better, we might know more when reports are due
